Claim 50% Off TipRanks Premium and Invest with Confidence
- Unlock hedge-fund level data and powerful investing tools designed to help you make smarter, sharper decisions
- Stay ahead of the market with the latest news and analysis so your portfolio is always positioned for maximum potential
Daito Pharmaceutical Co., Ltd. ( (JP:4577) ) has issued an update.
Daito Pharmaceutical Co., Ltd. announced a stock split to enhance stock liquidity and attract a broader investor base aligned with its growth strategy. The stock split, effective June 1, 2025, involves doubling the number of issued shares, with an amendment to the Articles of Incorporation reflecting the increased share authorization.
More about Daito Pharmaceutical Co., Ltd.
Daito Pharmaceutical Co., Ltd. operates in the pharmaceutical industry, focusing on the development and distribution of medicinal products. The company is listed on the Prime Market of the Tokyo Stock Exchange, indicating its significant presence in the financial market.
YTD Price Performance: -3.83%
Average Trading Volume: 24,028
Technical Sentiment Consensus Rating: Buy
Current Market Cap: Yen30.84B
For detailed information about 4577 stock, go to TipRanks’ Stock Analysis page.